Article summary
After publishing a new study investigating synthetic analogs for iboga molecules, scientist and co-founder of Gilgamesh Pharmaceuticals, Dalibor Sames, decided to take the compound he has described as an intelligent molecular machine. The post New Theories and Findings From The Frontier of Ibogaine Research first appeared on Lucid News. The post New Theories and Findings From The Frontier of Ibogaine Research appeared first on Lucid News.
Continue to the original publication for the complete article.